Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) with high heterogeneity is one of the most frequent malignant tumors. However, there were no studies to create a clinical stage-related gene signature for HCC patients. Differentially expressed genes (DEGs) associated with clinical stage of HCC were analyzed based on T...
Saved in:
| Main Authors: | Liu Yang, Long-fei Zeng, Guo-qing Hong, Qing Luo, Xing Lai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2022/6535009 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma
by: Xing Lai, et al.
Published: (2022-01-01) -
Construction and validation of a prognostic signature based on microvascular invasion and immune-related genes in hepatocellular carcinoma
by: Hao Li, et al.
Published: (2024-11-01) -
Construction and Validation of a Novel Butyrylation-Related Gene Signature Related to Prognosis, Clinical Implications, and Immune Microenvironment Characterization of Hepatocellular Carcinoma
by: Weiping Su, et al.
Published: (2025-01-01) -
Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
by: Wenbiao Chen, et al.
Published: (2020-01-01) -
Signature of immune-related metabolic genes predicts the prognosis of hepatocellular carcinoma
by: Weibin Zhuo, et al.
Published: (2024-11-01)